Estrofem 2 mg 28 Tablets Price in Turkey 2023 (Updated Price)
Estrofem 2 mg 28 Tablets is a hormone replacement therapy medication used to treat symptoms of menopause in women. It contains the active ingredient estradiol, a form of the female hormone estrogen. Estrofem is taken orally and helps to relieve hot flashes, night sweats, vaginal dryness and other symptoms associated with menopause.
It may also help to prevent osteoporosis in postmenopausal women. Estrofem is only available by prescription from a healthcare provider. It is important to follow the instructions of your doctor and read the medication guide before starting treatment with Estrofem.
| Drug Name: | Estrofem 2 mg 28 Tablets |
|---|---|
| Company: | Novo Nordisk Pharmaceuticals |
| Active ingredient: | Estradiol |
| ATC Code: | G03CA03 |
| Public Code: | A02835 |
| Barcode: | 8699676090266 |
| Price: | 266.97 TL |
| Prescription Type: | Regular Prescription |
| e-Prescription: | Active |
| Recruitment: | Buy your medicine only from the pharmacy! |
Estrofem Price
Estrofem 2 mg 28 Tablets, drug price: Sales including VAT announced by İEGM (TITCK) affiliated to the Ministry of Health of the Republic of Turkey as of 14.01.2024 price 266.97 TL is. This drug with barcode number 8699676090266, offered for sale by Novo Nordisk Pharmaceutical company, is in the Original drug class in the Original/Generic/Twenty-Year-Old classification.
Estrofem 2 mg 28 Tablet Active Ingredient
Estradiol
Chemical Structure Picture for the main active ingredient of Estrofem drug:
Category of Estrofem 2 mg 28 Tablet drug
Urogenital System and Sex Hormones – Sex Hormones and Genital System – Estrogen Hormone Drugs – Natural and Semisynthetic Estrogen Drugs – Estradiol
Estrofem 2 mg 28 Tablet Indications
Estrofem; In the treatment of estrogen (a group of steroid hormones that play an important role in women’s menstrual period) insufficiency symptoms (hot flashes, sleep disorders, urogenital atrophy, atrophic vaginitis, as well as accompanying mood changes) due to natural or post-operative menopause, postmenopausal (post-menopausal bleeding) ) is used to prevent accelerated bone loss. In patients who have not had a hysterectomy, estrogen must be supplemented with a sequential progestin.
Please note that the information provided on this website is for informational purposes only. It is not intended as a substitute for professional medical advice, diagnosis, or treatment. Therapidya does not take any responsibility for the accuracy or reliability of the information provided on this website or for the consequences of self-treatment with the medicines described. Always seek the advice of a qualified healthcare provider if you have any questions about a medical condition or treatment.
This post is also available in: العربية (Arabic) Français (French) Deutsch (German) Русский (Russian)
